Sarah H. Heil, PhD; Heidi S. Melbostad, PhD; Alexis K. Matusiewicz, PhD; et al.
free access
JAMA Psychiatry. 2021;78(10):1071-1078. doi:10.1001/jamapsychiatry.2021.1715
This randomized clinical trial assesses whether offering usual care, contraceptive services without incentives, or contraceptive services with incentives in opioid use disorder treatment programs results in a graded increase in prescription contraceptive use and produces cost-benefits.
Felicia Ceban, HBSc; Danica Nogo, HBSc; Isidro P. Carvalho, HBSc; et al.
free access
JAMA Psychiatry. 2021;78(10):1079-1091. doi:10.1001/jamapsychiatry.2021.1818
This systematic review and meta-analysis assesses whether preexisting mood disorders are associated with a higher risk of COVID-19 susceptibility, hospitalization, severe complications, or death.
Hypatia A. Bolívar, PhD; Elias M. Klemperer, PhD; Sulamunn R. M. Coleman, PhD; et al.
open access
has audio
JAMA Psychiatry. 2021;78(10):1092-1102. doi:10.1001/jamapsychiatry.2021.1969
This systematic review and meta-analysis examines the efficacy of contingency management for treating comorbid behavioral problems in individuals receiving medication for opioid use disorder.
-
Podcast:
Contingency Management for Patients Receiving Medication for Opioid Use Disorder
Lies de Haan, BSc; Arjen L. Sutterland, MD; Jasper V. Schotborgh, MD; et al.
free access
JAMA Psychiatry. 2021;78(10):1103-1112. doi:10.1001/jamapsychiatry.2021.1590
This systematic review and meta-analysis uses data from observational studies to examine the association between Toxoplasma gondii infection and cognitive function among otherwise healthy individuals.
Vanessa M. Brown, PhD; Lusha Zhu, PhD; Alec Solway, PhD; et al.
open access
JAMA Psychiatry. 2021;78(10):1113-1122. doi:10.1001/jamapsychiatry.2021.1844
This mixed cross-sectional鈥揷ohort study evaluates associations among computational model鈥揹erived reinforcement learning parameters, depression symptoms, and symptom changes after cognitive behavioral therapy.
Guido K. W. Frank, MD; Megan E. Shott, BS; Joel Stoddard, MD; et al.
open access
JAMA Psychiatry. 2021;78(10):1123-1133. doi:10.1001/jamapsychiatry.2021.1580
This cross-sectional study assesses brain response during unexpected receipt or omission of a salient sweet stimulus in women with eating disorders and healthy controls to test for evidence of whether this brain response is associated with the ventral striatal-hypothalamic circuitry.
Philippe R. Goldin, PhD; Matthew Thurston, MS; Santiago Allende, MS; et al.
free access
JAMA Psychiatry. 2021;78(10):1134-1142. doi:10.1001/jamapsychiatry.2021.1862
This randomized clinical trial investigates the effects of cognitive behavioral group therapy and mindfulness-based stress reduction on reappraisal and acceptance in patients with social anxiety disorder and tests whether treatment-associated brain changes are associated with social anxiety symptoms 1 year posttreatment.
Sophie E. Legge, PhD; Alastair G. Cardno, PhD; Judith Allardyce, PhD; et al.
open access
JAMA Psychiatry. 2021;78(10):1143-1151. doi:10.1001/jamapsychiatry.2021.1961
This genetic association study examines the associations between phenotypic dimensions in schizophrenia and genetic liability to schizophrenia, other neuropsychiatric disorders, and intelligence in patients with schizophrenia.
Brittany L. Mitchell, MSc; Jackson G. Thorp, BSc; Yeda Wu, MD; et al.
free access
JAMA Psychiatry. 2021;78(10):1152-1160. doi:10.1001/jamapsychiatry.2021.1988
This case-control study examines the association between the depth of phenotyping and estimation of the risk for major depression disorder in genetic studies.